Showing results (891-900 of 9,066) with videos related to

Sort By:
Pageof 907
Rheumatology (Oxford, England)|March 26, 2008
Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritisB Galarraga, M Ho, H M Youssef, et al.
Rheumatology (Oxford, England)|April 9, 2008
Glucocorticoid treatment inhibits annexin-1 expression in rheumatoid arthritis CD4+ T cellsF D'Acquisto, N Paschalidis, K Raza, et al.
Rheumatology (Oxford, England)|April 9, 2008
Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesionsN Hiramatsu, T Kuroiwa, H Ikeuchi, et al.
Rheumatology (Oxford, England)|March 22, 2008
Low disease activity state with corticosteroid may not represent 'true' low disease activity state in patients with rheumatoid arthritisN Iikuni, E Inoue, E Tanaka, et al.
Rheumatology (Oxford, England)|January 19, 2006
Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patientsF K Tan, X Zhou, M D Mayes, et al.
Rheumatology (Oxford, England)|February 2, 2006
Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-kappaB and p38T Hiramitsu, T Yasuda, H Ito, et al.
Rheumatology (Oxford, England)|February 2, 2006
Association of a non-synonymous single-nucleotide polymorphism of DNASEI with SLE susceptibilityA Bodaño, A González, I Ferreiros-Vidal, et al.
Rheumatology (Oxford, England)|February 2, 2006
Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosisF Ogawa, K Shimizu, E Muroi, et al.
Rheumatology (Oxford, England)|January 10, 2006
Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatmentJ-S F Sanders, M G Huitma, C G M Kallenberg, et al.
Rheumatology (Oxford, England)|January 13, 2006
Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutationsH J Lachmann, B Sengül, T U Yavuzşen, et al.
Pageof 907